These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 33222153)

  • 21. Multiple myeloma: diagnosis and treatment.
    Rajkumar SV; Kyle RA
    Mayo Clin Proc; 2005 Oct; 80(10):1371-82. PubMed ID: 16212152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total therapy-based treatment for multiple myeloma--a single center experience.
    Magen-Nativ H; Ram R; Yeshurun M; Gafter-Gvili A; Raanani P; Shpilberg O
    Ann Hematol; 2010 Jan; 89(1):53-9. PubMed ID: 19504094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current treatments for renal failure due to multiple myeloma.
    Gavriatopoulou M; Terpos E; Kastritis E; Dimopoulos MA
    Expert Opin Pharmacother; 2016 Nov; 17(16):2165-2177. PubMed ID: 27646819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results.
    Morgan GJ; Davies FE; Gregory WM; Bell SE; Szubert AJ; Navarro Coy N; Cook G; Feyler S; Johnson PR; Rudin C; Drayson MT; Owen RG; Ross FM; Russell NH; Jackson GH; Child JA;
    Haematologica; 2012 Mar; 97(3):442-50. PubMed ID: 22058209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial.
    Kumar SK; Jacobus SJ; Cohen AD; Weiss M; Callander N; Singh AK; Parker TL; Menter A; Yang X; Parsons B; Kumar P; Kapoor P; Rosenberg A; Zonder JA; Faber E; Lonial S; Anderson KC; Richardson PG; Orlowski RZ; Wagner LI; Rajkumar SV
    Lancet Oncol; 2020 Oct; 21(10):1317-1330. PubMed ID: 32866432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantation.
    Masina L; Bianchetti N; Passi A; Bottelli C; Bagnasco S; Spolzino A; Oberti M; Chiarini M; Belotti A; Voltolini S; Faglioni L; Rossi G; Tucci A; Cattaneo C
    Hematol Oncol; 2023 Aug; 41(3):555-558. PubMed ID: 36786526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report.
    Madduri D; Parekh S; Campbell TB; Neumann F; Petrocca F; Jagannath S
    J Med Case Rep; 2021 Feb; 15(1):90. PubMed ID: 33608053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
    Gay F; Oliva S; Petrucci MT; Conticello C; Catalano L; Corradini P; Siniscalchi A; Magarotto V; Pour L; Carella A; Malfitano A; Petrò D; Evangelista A; Spada S; Pescosta N; Omedè P; Campbell P; Liberati AM; Offidani M; Ria R; Pulini S; Patriarca F; Hajek R; Spencer A; Boccadoro M; Palumbo A
    Lancet Oncol; 2015 Dec; 16(16):1617-29. PubMed ID: 26596670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modern treatments and future directions for newly diagnosed multiple myeloma patients.
    Lu SX
    Best Pract Res Clin Haematol; 2020 Mar; 33(1):101151. PubMed ID: 32139016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral blood progenitor cell mobilisation in patients with multiple myeloma following oral idarubicin and dexamethasone (Z-Dex) induction therapy.
    Cook G; Marinaki P; Farrell E; Pearson C; Alcorn MJ; Sharp RA; Tansey PJ; Franklin IM
    Leukemia; 1997 Dec; 11 Suppl 5():S35-40. PubMed ID: 9436937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I trial of first-line bortezomib/thalidomide plus chemotherapy for induction and stem cell mobilization in patients with multiple myeloma.
    Badros A; Goloubeva O; Fenton R; Rapoport AP; Akpek G; Harris C; Ruehle K; Westphal S; Meisenberg B
    Clin Lymphoma Myeloma; 2006 Nov; 7(3):210-6. PubMed ID: 17229337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study.
    Camilleri M; Cuadrado M; Phillips E; Wilson W; Jenner R; Pang G; Kamora S; Streetly M; Popat R; Bygrave C; Owen R; Cavenagh J; Chapman M; Sive J; Eccersley L; Sheaff M; Benjamin R; Ramasamy K; Cook G; Virchis A; Chavda SJ; Clifton-Hadley L; Scully MA; Yong K
    Br J Haematol; 2021 May; 193(4):750-760. PubMed ID: 33650100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy.
    Quach H; Nooka A; Samoylova O; Venner CP; Kim K; Facon T; Spencer A; Usmani SZ; Grosicki S; Suzuki K; Delimpasi S; Weisel K; Obreja M; Zahlten-Kumeli A; Mateos MV
    Br J Haematol; 2021 Aug; 194(4):784-788. PubMed ID: 34046887
    [No Abstract]   [Full Text] [Related]  

  • 34. COVID-19 infection in patients with multiple myeloma: a German-Chinese experience from Würzburg and Wuhan.
    Zhou X; Bai T; Meckel K; Song J; Jin Y; Kortüm KM; Einsele H; Hou X; Rasche L
    Ann Hematol; 2021 Mar; 100(3):843-846. PubMed ID: 32683456
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of exercise in combination with epoetin alfa during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for multiple myeloma.
    Coleman EA; Coon SK; Kennedy RL; Lockhart KD; Stewart CB; Anaissie EJ; Barlogie B
    Oncol Nurs Forum; 2008 May; 35(3):E53-61. PubMed ID: 18467280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclophosphamide mobilization does not improve outcome in patients receiving stem cell transplantation for multiple myeloma.
    Dingli D; Nowakowski GS; Dispenzieri A; Lacy MQ; Hayman S; Litzow MR; Gastineau DA; Gertz MA
    Clin Lymphoma Myeloma; 2006 Mar; 6(5):384-8. PubMed ID: 16640814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photoclinic Diagnosis: Puffy Hands as the Initial Manifestation of Multiple Myeloma.
    Shariati-Sarabi Z; Alirezaei A; Azadeh H; Monzavi SM; Mozaheb Z
    Arch Iran Med; 2016 Oct; 19(10):741-742. PubMed ID: 27743441
    [No Abstract]   [Full Text] [Related]  

  • 38. Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.
    Rosiñol L; Beksac M; Zamagni E; Van de Donk NWCJ; Anderson KC; Badros A; Caers J; Cavo M; Dimopoulos MA; Dispenzieri A; Einsele H; Engelhardt M; Fernández de Larrea C; Gahrton G; Gay F; Hájek R; Hungria V; Jurczyszyn A; Kröger N; Kyle RA; Leal da Costa F; Leleu X; Lentzsch S; Mateos MV; Merlini G; Mohty M; Moreau P; Rasche L; Reece D; Sezer O; Sonneveld P; Usmani SZ; Vanderkerken K; Vesole DH; Waage A; Zweegman S; Richardson PG; Bladé J
    Br J Haematol; 2021 Aug; 194(3):496-507. PubMed ID: 33724461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential treatment with bortezomib plus dexamethasone followed by autologous hematopoietic stem cell transplantation in patients with multiple myeloma.
    Zheng D; Li J; Huang BH; Liu JR; Zou WY; Su C
    Chin Med J (Engl); 2012 Dec; 125(24):4454-9. PubMed ID: 23253719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pembrolizumab, lenalidomide and dexamethasone post autologous transplant in patients with high-risk multiple myeloma.
    Biran N; Gourna Paleoudis E; Feinman R; Vesole DH; Zenreich J; Wang S; Ahn J; Bansal M; Rowley S; Donato M; Pecora AL; Richter J; Anand P; McBride L; Ivanovski K; Korngold R; Siegel DS
    Am J Hematol; 2021 Nov; 96(11):E430-E433. PubMed ID: 34435374
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.